Company page
Kailera Therapeutics, Inc.
Kailera Therapeutics, Inc. is a public company traded under the ticker KLRA in the American market. With a market capitalization of approximately $2.58 billion, the company focuses on developing innovative therapies. Kailera is dedicated to advancing treatment options in the biotechnology sector.
- Ticker
- KLRA:NASDAQ
- Asset type
- Stock
- Market cap
- $2.58B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD